Symbol="TRVI"
AssetType="Common Stock"
Name="Trevi Therapeutics Inc"
Description="Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the development and commercialization of Haduvio to treat serious neurology-mediated conditions. The company is headquartered in New Haven, Connecticut."
CIK="1563880"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="195 CHURCH STREET, 14TH FLOOR, NEW HAVEN, CT, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="135156000"
EBITDA="-30394000"
PERatio="None"
PEGRatio="None"
BookValue="1.694"
DividendPerShare="0"
DividendYield="0"
EPS="-0.31"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.26"
ReturnOnEquityTTM="-0.503"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.31"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="7.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.27"
EVToRevenue="-"
EVToEBITDA="-0.805"
Beta="0.749"
num_52WeekHigh="4.683"
num_52WeekLow="1.43"
num_50DayMovingAverage="2.62"
num_200DayMovingAverage="2.233"
SharesOutstanding="60070000"
DividendDate="None"
ExDividendDate="None"
symbol="TRVI"
open="2.21"
high="2.27"
low="2.16"
price="2.25"
volume="77711.00"
latest_trading_day="2023-07-07"
previous_close="2.27"
change="-0.02"
change_percent="-0.8811%"
aroon_positive_momentum_days="68"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="68"
Volume_recent_avg="263588"
Change_recent_avg="-0.01"
Delta_recent_avg="0.2"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="-0.5"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="68"
Aroon_momentum_negative="32"
image_negative_thumbnail_id_1="102"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0074.jpeg"
image_negative_thumbnail_id_2="1100"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0133.jpeg"
image_neutral_thumbnail_id_1="591"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_neutral_thumbnail_id_2="522"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0077.jpeg"
image_positive_thumbnail_id_1="983"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0145.jpeg"
image_positive_thumbnail_id_2="975"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
